The \u2018Delivery plan for tackling the COVID-19 backlog of elective care\u2019 how the National Health Service will recover and expand elective services over the next three years, including in Wakefield. We have allocated more than £8 billion from 2022/23 to 2024/25, in addition to the £2 billion Elective Recovery Fund and £700 million Targeted Investment Fund already made available in 2021/2022 to increase elective activity. This funding aims to deliver the equivalent of approximately nine million additional checks and procedures and 30% further elective activity by 2024/25 than pre-pandemic levels. A proportion of this funding will be invested in workforce capacity and training and we have committed to invest £5.9 billion for new beds, equipment and technology.<\/p>
The target to eliminate waiting times of two years or more for elective procedures was met in July 2022 and we aim to eliminate waiting time of eighteen months or more by April 2023. This will be achieved through increasing capacity, seeking alternate capacity in other trusts or the independent sector and engaging with patients to understand choices made regarding their care.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4320", "label" : {"_value" : "Biography information for Robert Jenrick"} } , "answeringMemberConstituency" : {"_value" : "Newark"} , "answeringMemberPrinted" : {"_value" : "Robert Jenrick"} , "dateOfAnswer" : {"_value" : "2022-10-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1522399/answer/previousversion/25037", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4320", "label" : {"_value" : "Biography information for Robert Jenrick"} } , "answeringMemberConstituency" : {"_value" : "Newark"} , "answeringMemberPrinted" : {"_value" : "Robert Jenrick"} } , "questionFirstAnswered" : [{"_value" : "2022-10-24T10:47:22.663Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-10-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Surgery: Worsley and Eccles South"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help reduce waiting times for elective surgeries in Worsley and Eccles South constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1588", "label" : {"_value" : "Biography information for Barbara Keeley"} } , "tablingMemberConstituency" : {"_value" : "Worsley and Eccles South"} , "tablingMemberPrinted" : [{"_value" : "Barbara Keeley"} ], "uin" : "63153"} , {"_about" : "http://data.parliament.uk/resources/1504846", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1504846/answer", "answerText" : {"_value" : "
The Government has decided not to procure Evusheld for prevention through emergency routes at this time. This is a decision based on independent clinical advice by the multi-agency initiative, RAPID C-19 and a national expert policy working group. These groups considered a range of evidence, including clinical trial data, in vitro analysis and emerging observational studies and concluded there is currently insufficient evidence of benefit to recommend deployment. The Chief Medical Officer for England is content that the correct process for providing clinical advice has been followed and agree that this should now be referred to the National Institute for Health and Care Excellence for further evaluation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4320", "label" : {"_value" : "Biography information for Robert Jenrick"} } , "answeringMemberConstituency" : {"_value" : "Newark"} , "answeringMemberPrinted" : {"_value" : "Robert Jenrick"} , "dateOfAnswer" : {"_value" : "2022-09-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-09-22T15:45:43.817Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-09-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Tixagevimab/cilgavimab"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether the Government took account of the recent Israeli study on the efficacy of Evusheld, published on 29 July 2022, as part of its decision on whether to procure Evusheld.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1588", "label" : {"_value" : "Biography information for Barbara Keeley"} } , "tablingMemberConstituency" : {"_value" : "Worsley and Eccles South"} , "tablingMemberPrinted" : [{"_value" : "Barbara Keeley"} ], "uin" : "47497"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }